Bloodstream infections in febrile neutropenic children with cancer

被引：0
|
作者：
Hikawa, Renato
Petrilli, A. Sergio
Goto, Janaina
Carlesse, Fabianne
Aguiar, Maria Aparecida
Marra, Alexandre
Pereira, Carlos Alberto
机构：
[1] Univ Fed Sao Paulo, Pediat Oncol Inst, Dept Pediat, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Pediat Oncol Inst, Dept Infect Dis, Sao Paulo, Brazil
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/S1201-9712(08)60086-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
84
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [21] Etiology of bacterial infections in febrile neutropenic patients
    Poyart, C
    Morand, P
    Buzyn, A
    PRESSE MEDICALE, 2004, 33 (07): : 460 - 466
  • [22] Development and Validation of a Prediction Model for Diagnosing Blood Stream Infections in Febrile, Non-Neutropenic Children With Cancer
    Esbenshade, Adam J.
    Di Pentima, M. Cecilia
    Zhao, Zhiguo
    Shintani, Ayumi
    Esbenshade, Jennifer C.
    Simpson, Monique E.
    Montgomery, Kathleen C.
    Lindell, Robert B.
    Lee, Haerin
    Wallace, Ato
    Garcia, Kelly L.
    Moons, Karel G. M.
    Friedman, Debra L.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 262 - 268
  • [23] Study of secondary infections in febrile neutropenic patients
    Jordan, Rosana
    Giorgio, Patricia
    Martinez, Jorge V.
    Verbanaz, Sergio
    Enriquez, Natalia
    Thierer, Jorge
    Khoury, Marina
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : S35 - S35
  • [24] Factors related to bloodstream infections in children with cancer
    Doganis, Dimitrios
    Pourtsidis, Apostolos
    Lebessi, Evangelia
    Bouhoutsou, Despina
    Baka, Margarita
    Varvoutsi, Maria
    Foustoukou, Maria
    Kafetzis, Dimitrios
    Kosmidis, Helen
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 483 - 483
  • [25] Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients
    Marie, JP
    Vekhoff, A
    Pico, JL
    Guy, H
    Andremont, A
    Richet, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 : 57 - 64
  • [26] Imipenem in the Treatment of Febrile Neutropenic Children
    Erbey, Fatih
    Bayram, Ibrahim
    Yilmaz, Sema
    Tanyeli, Atila
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (05) : 921 - 923
  • [27] Meropenem in the treatment of febrile neutropenic children
    Müller, J
    Garami, M
    Constantin, T
    Schmidt, M
    Fekete, G
    Kovács, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22 (04) : 277 - 284
  • [28] Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
    Zhao, Zhiguo
    Patel, Pratik A.
    Slatnick, Leonora
    Sitthi-Amorn, Anna
    Bielamowicz, Kevin J.
    Nunez, Farranaz A.
    Walsh, Alexandria M.
    Hess, Jennifer
    Rossoff, Jenna
    Elgarten, Caitlin
    Myers, Regina
    Saab, Raya
    Basbous, Maya
    Mccormick, Meghan
    Aftandilian, Catherine
    Richards, Rebecca
    Nessle, C. Nathan
    Tribble, Alison C.
    Bhutada, Jessica K. Sheth
    Coven, Scott L.
    Runco, Daniel
    Wilkes, Jennifer
    Gurunathan, Arun
    Guinipero, Terri
    Belsky, Jennifer A.
    Lee, Karen
    Wong, Victor
    Malhotra, Megha
    Armstrong, Amy
    Jerkins, Lauren P.
    Cross, Shane J.
    Fisher, Lyndsay
    Stein, Madison T.
    Wu, Natalie L.
    Yi, Troy
    Orgel, Etan
    Haeusler, Gabrielle M.
    Wolf, Joshua
    Demedis, Jenna M.
    Miller, Tamara P.
    Esbenshade, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (07) : 832 - 841
  • [29] The role of proangiogenic cytokines in predicting sepsis in febrile neutropenic children with cancer
    Cakmakci, Selma
    Sari, Neriman
    Sonmez, Cigdem
    Ilhan, Inci Ergurhan
    TURKISH JOURNAL OF PEDIATRICS, 2024, 66 (01) : 90 - 98
  • [30] Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: A prospective study
    Santolaya, ME
    Villarroel, M
    Avendano, LF
    Cofre, J
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) : 92 - 97
12345